Desjardins raised the firm’s price target on Kits Eyecare (KTYCF) to C$25 from C$23 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KTYCF:
- Kits Eyecare Hits Record 2025 Revenue as Eyeglasses and AI Platform Drive Growth
- KITS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Reinvestment-Fueled Growth in High-Margin Glasses Supports Buy Rating on KITS
- Kits Eyecare management to meet with Roth Capital
- KITS: Sustained High-Growth Vision with Strategic ‘Land-Grab’ in High-Margin Glasses Supports Buy Rating